Elective Adhesiolysis vs. a Wait-and-see Policy to Prevent Recurrences After Conservative Treatment of Adhesive Small Bowel Obstruction

NCT ID: NCT06777446

Last Updated: 2025-01-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

380 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-02-28

Study Completion Date

2034-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Rationale: Adhesive small bowel obstruction (aSBO) is a frequent surgical emergency, associated with 3-8% hospital mortality and a high risk of recurrence (20% at two years of follow-up). ASBO can be treated conservatively or by emergency surgery. In the absence of bowel ischemia or strangulation, conservative treatment is often preferred, to avoid the excess morbidity and mortality from emergency surgery. Recent epidemiological studies, however, demonstrate a considerable higher recurrence risk of aSBO after conservative treatment that is associated with hospital readmissions and lower survival. Elective adhesiolysis following successful conservative treatment might reduce these long-term risks whilst avoiding the high complication rate of emergency surgery.

Objective: The investigators aim to assess the efficacy of elective adhesiolysis following conservative treatment for aSBO as compared to the current state of the art (wait-and-see policy) to prevent long-term recurrence of aSBO. Further the investigators will evaluate quality of life, healthcare and societal costs.

Study design: Multicenter open-label randomized controlled trial, including 380 patients.

Study population: Adult patients who recovered from aSBO by conservative treatment. Patients that are inoperable for medical, anaesthesiological or surgical reasons are excluded. Intervention (if applicable): The intervention of investigation is elective adhesiolysis. Adhesiolysis is an abdominal procedure in which all adhesions are cut, and adhesion prevention applied to reduce the risk of adhesion reformation. The intervention is compared to wait-and-see policy (the current standard treatment)

Main study parameters/endpoints: Primary outcome is recurrence, defined as readmission for obstructive systems with aetiology of adhesions confirmed by CT. The investigators hypothesize a 50% reduction in recurrence in the intervention arm. Secondary outcomes are morbidity from surgery, health-related quality of life (EQ5D), healthcare costs and societal costs (iMCQ and iPCQ)

Nature and extent of the burden and risks associated with participation, benefit and group relatedness:

Patients in the intervention group are exposed to abdominal surgery, which is associated with a moderate risk of minor complications such as wound infection and haemorrhage, and a small risk of severe complications such as iatrogenic bowel injury. According to our hypothesis, a potential benefit is the reduction in the risk of recurrences. Recurrence of aSBO is associated with a risk of readmissions, reinterventions, and also increased long-term mortality.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adhesive Small Bowel Obstruction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Multicenter open-label randomized controlled trial
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Elective Adhesiolysis

Elective adhesiolysis is a surgical procedure in which all adhesions in the abdomen are released. Elective adhesiolysis is preferably performed laparoscopy, but the precise surgical approach is adjusted to the expected location and extent of the adhesions based on factors including: presence of a stoma, abdominal wall defects, as well as the surgical history and locations of previous scarring.

Group Type EXPERIMENTAL

Elective Adhesionlysis

Intervention Type PROCEDURE

See descriptions in study arms

Adhesion barrier

Intervention Type DEVICE

At the end of adhesiolysis a barrier will be placed. The adhesion barrier to be used in laparoscopic adhesiolysis is Icodextrin 4% (Adepttm).

Wait-and-see policy

A Wait-and-see policy is the current standard of care after a non-operatively treated epsiode of ASBO. No specific intervention or follow-up is performed in the control group of wait-and-see policy.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Elective Adhesionlysis

See descriptions in study arms

Intervention Type PROCEDURE

Adhesion barrier

At the end of adhesiolysis a barrier will be placed. The adhesion barrier to be used in laparoscopic adhesiolysis is Icodextrin 4% (Adepttm).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients aged 18 years and older who have recently recovered from aSBO by small bowel obstruction managed by conservative treatment.
* Patients who have previously been operated (high a prior risk of adhesions) are required to have no signs of other causes of bowel obstruction on imaging studies (CT-scan).
* Patients with no previous operation in history (low a prior risk of adhesions) are required to have typical signs for aSBO on imaging studies (abrupt change of bowel calibre, closed loop, or signs of torsion on vessels in the mesentery on CT-scan).

Exclusion Criteria

* Patient who are unfit for reoperation for surgical, anesthesiological or medical reasons as determined by multidisciplinary team assessment or pre-operative screening
* Patients with active malignancy, reducing life expectancy
* Pregnancy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

Sponsor Role collaborator

KCE Belgian Healthcare Knowledge Centre

UNKNOWN

Sponsor Role collaborator

Baxter Healthcare Corporation

INDUSTRY

Sponsor Role collaborator

Radboud University Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UZ Antwerpen

Antwerp, , Belgium

Site Status

Hôpital Erasme

Brussels, , Belgium

Site Status

UZ Brussel

Brussles, , Belgium

Site Status

UZ Leuven (National Coordinating Center)

Leuven, , Belgium

Site Status

Vitaz Sint-Niklaas

Sint-Niklaas, , Belgium

Site Status

ZGT Almelo

Almelo, , Netherlands

Site Status

OLVG Amsterdam

Amsterdam, , Netherlands

Site Status

Maasziekenhuis Pantein Boxmeer

Boxmeer, , Netherlands

Site Status

St. Jansdal Harderwijk

Harderwijk, , Netherlands

Site Status

MaastrichtUMC+

Maastricht, , Netherlands

Site Status

RadboudUMC

Nijmegen, , Netherlands

Site Status

Laurentius Ziekenhuis Roermond

Roermond, , Netherlands

Site Status

St. Franciscus gasthuis Rotterdam

Rotterdam, , Netherlands

Site Status

Vie Curie Venlo

Venlo, , Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium Netherlands

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Richard PG ten Broek, MD, PhD

Role: CONTACT

+31243611111

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Michiel de Maat, MD, PhD

Role: primary

+32 3 821 30 00

Nalja Bachir, MD, PhD

Role: primary

+32 2 555 31 11

Jasper Stijns, MD, PhD

Role: primary

+32 2 477 41 11

Albert Wolthuis, Prof, MD, PhD

Role: primary

+32 16 33 22 11

Jean-Baptiste Cornille, MD, PhD

Role: primary

+323 760 60 60

Esther van den Ende, MD, PhD

Role: primary

+3188 708 7878

Steve de Castro, MD, PhD

Role: primary

+3120 599 9111

Klaas Govaert, MD, PhD

Role: primary

+31485 845 000

Caroline Andeweg, MD, PhD

Role: primary

+31 341 463 911

Tim Lubbers, MD, PhD

Role: primary

+3143 387 6543

Richard PG ten Broek, MD, PhD

Role: primary

+31243611111

Jeroen Heemskerk, MD, PhD

Role: primary

+31475 382 222

Eva Deerenberg, MD, PhD

Role: primary

+3110 461 6161

Frits Aarts, MD, PhD

Role: primary

+3177 320 5555

References

Explore related publications, articles, or registry entries linked to this study.

Krielen P, Kranenburg LPA, Stommel MWJ, Bouvy ND, Tanis PJ, Willemsen JJ, Migchelbrink J, de Ree R, Bormans EMG, van Goor H, Ten Broek RPG; ASBO Snapshot Study Group. Variation in the management of adhesive small bowel obstruction in the Netherlands: a prospective cross-sectional study. Int J Surg. 2023 Aug 1;109(8):2185-2195. doi: 10.1097/JS9.0000000000000471.

Reference Type BACKGROUND
PMID: 37288588 (View on PubMed)

van den Beukel BAW, Toneman MK, van Veelen F, van Oud-Alblas MB, van Dongen K, Stommel MWJ, van Goor H, Ten Broek RPG. Elective adhesiolysis for chronic abdominal pain reduces long-term risk of adhesive small bowel obstruction. World J Emerg Surg. 2023 Jan 23;18(1):8. doi: 10.1186/s13017-023-00477-9.

Reference Type BACKGROUND
PMID: 36691000 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NL88020.091.24

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hernia Prevention in Stomas
NCT00907842 COMPLETED NA
Treating Parastomal Hernia With a Mesh
NCT02233465 COMPLETED PHASE1/PHASE2